KMT2D and adenocarcinoma: KDM6A and KMT2D mutations have been reported in the appendiceal goblet cell carcinoid, mixed goblet cell carcinoid–adenocarcinoma, and some appendiceal mucinous adenocarcinomas and adenocarcinomas [31,35].